Ngl Fine-Chem has informed that the Company has received Certificate of suitability No. CEP 2022-025 - Rev 00, from European Directorate for the Quality of Medicines & Healthcare (EDQM) for its product Triclabendazole. This certificates facilitates registration and use of Triclabendazole manufactured by NGL Fine-Chem by the European customers for their finished product.
The above information is a part of company’s filings submitted to BSE.